Owner CURAGEN CORPORATION

Inventors Zerhusen, Bryan, D.; Guo, Xiaojia; Burgess, Catherine, E.; Miller, Charles; Vernet, Corine, A., M.; Stone, David, J.; Lepley, Denise, M.; Boldog, Ferenc; Smithson, Glennda; Millett, Isabelle; Baumgartner, Jason; Herrmann, John; MacDougall, John; Peyman, John, A.; Alsobrook, John, P., II; Ellerman, Karen; Spytek, Kimberly, A.; Li, Li; Gorman, Linda; Rothenberg, Mark; Patturajan, Meera; Padigaru, Muralidhara; Mezes, Peter; Kekuda, Ramesh; Taupier, Raymond, J., Jr.; Shimkets, Richard, A.; Edinger, Scholmit; C

Agent Cullens

Pub. Number AU-A-2002306414

PCT Number PCT/US02/01311

PCT Pub. Number WO2002/068647

Priority 60/265,530 31.01.01 US; 60/268,595 14.02.01 US; 60/272,409 28.02.01 US; 60/276,777 16.03.01 US; 60/291,672 17.05.01 US; 60/325,306 27.09.01 US; 60/330,336 18.10.01 US; Not Given 09.11.01 US; 60/261,376 16.01.01 US; 60/262,454 18.01.01 US; 60/262,587 18.01.01 US

Filing date 16 January 2002

Wipo publication date 12 September 2002

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C07K 014/47 Peptides having more than 20 amino acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay